ITP team GreenMark Biomedical Secures Third NIH Grant in 2025•ITP team RevBio® Receives First FDA Approval for a “Bone Glue” to Treat Extremity Fractures in a Clinical Trial•Insights on Engineering and Biofabrication of Early Cancer Models: ITP PI, Luiz Bertassoni's review published in Nature Reviews Bioengineering•ITP PI Luiz Bertassoni's work on early cancer detection and treatment featured in multiple outlets!•IADR Connect webinar, Phosphate, Proteins, and Patterning: Unraveling the Rules of Biomineralization•Biomaterial vaccines to make implanted orthopedic devices safer, Work by TRC Principal Investigator, David Mooney, highlighted and published in PNAS!•Congratulations to our TRC PI, Dr. David Mooney for winning the 2026 CMBE Award!•RevBio Receives a $2.2 Million Phase II NIH Grant to Further Develop the Minimally Invasive Use of TETRANITE® to Treat Complex Spine Fractures•2nd Global Symposium on Artificial Intelligence in Dentistry - November 14-15, 2025•Congratulations to our ITP team, GreenMark Biomedical, on making the finalist list for 2025 dentech!

Intellectual Property Strategy

The Translational Resource Center provides expertise to help investigators identify, evaluate, and analyze intellectual property (IP) opportunities related to their technologies. This process assists researchers in understanding their technology and the relevant patent landscape to maximize their research innovations.

Contact translationalrc@umich.edu for specific guidance and/or more information about the IP services available.